Bedrocan’s medicinal cannabis production not affected by COVID-19 crisis

In an online video interview with Marijuana Business Daily, CEO Tjalling Erkelens explains that the measures to curb the spread of the coronavirus do not yet affect Bedrocan’s production of medicinal cannabis. You cannot keep patients waiting for medication, which is why the company has taken all the necessary measures to ensure that production – which serves many patients in Europe – goes according to plan. “We can produce for the next few months undisrupted”, says Erkelens.

According to Erkelens, the coronavirus outbreak once again underlines the importance of scientifically based knowledge and, thus, also scientific research. “These uncertain times will hopefully teach us that money is way less important than people’s health. We have to lean on science as our guide in staying healthy.”